The report will be delivered in 2-3 business days.

Generic Pharmaceuticals Global Market Report 2020

Generic Pharmaceuticals
Purchase Options
Request Sample
Request For Discount
FAQ

Starting Price : $ 4000.00 | Pages : 200 | Published : January 2020 | SKU CODE : 7106 | Format :


Description Table Of Contents Tables & Figures Market Insights Related Reports

The generic pharmaceuticals market consists of sales of generic pharmaceuticals and related services. A generic medicine is a medication designed to be identical as branded drugs marketed by private companies in dosage form, strength, safety, route of administration, performance characteristics, quality, and intended use. Generic drugs work in the same way as branded drugs in terms of clinical benefits. Generic drugs are manufactured after the expiration of the exclusive rights or patent of the branded drugs. For example, some of the generic drugs in the generic pharmaceuticals market include metformin, metoprolol, acarbose, acebutolol, aztreonam and many more.

The global generic pharmaceuticals market was valued at about $216.94 billion in 2018 and is expected to grow to $309.16 billion at a CAGR of 9.3% through 2022.

The North American region has the largest market share in the generic pharmaceuticals market. Also, the Asia Pacific region is the fastest growing regional market in the generic pharmaceuticals market.

The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more individuals are diagnosed with chronic diseases, they look for more medicines for the treatment. Branded drugs come at a premium price, while generic drugs are available at a lower cost having the same chemical composition of branded drugs. The low cost and same chemical composition and strength of generic drugs make a patient buy generic drugs instead of branded drugs. If it is a chronic disease, the treatment goes for a longer period of time and hence, the sales of generic drugs also increase. For instance, according to the WHO (World Health Organization) report 2014, over the next 10 years, the deaths due to chronic disease is projected to increase by 17%. Also, it is expected that by 2020, almost 3-quarters of all deaths in the world will be due to chronic diseases.

The lack of awareness about generic drugs is one of the restraints on the generic pharmaceuticals market. The high marketing and advertisement of branded drugs overshadow the availability of generic drugs which are substitute for expensive branded drugs. Thus, consumers opt branded drugs despite the fact that the generic drugs carry the same chemical formulation as their counter branded drugs. According to an article published on CVS HEALTH website in 2017, many doctors and pharmacists preferred to offer branded drugs to their patients over generic drugs. This prevents the patients to go for generic drugs as they develop a preconceived notion of generic drugs not being at par with branded drugs. For example, according to a research conducted by Sahana K Hebbar, in 2017 on International Journal of Basic & Clinical Pharmacology, out of 100 patients and 50 non-medical staff, 95% of the patients and 60% of the non-medical staff didn't know about generic drugs. Thus, lack of awareness about the availability of generic drugs hamper the generic pharmaceuticals market.

3D printing technology has the ability to transform the manufacturing of drugs in the generic pharmaceuticals market. 3D printed pharmaceuticals helps in improve R&D productivity and deliver new benefits to patients. 3D printing allows the manufacturer to produce drugs with customized size, shape, and texture which is not possible in traditional manufacturing of generic drugs. 3D printing can help the manufacturer to make generic drugs that have different release dates, appearances and taste. For example, in 2017, GlaxoSmithKline (GSK) completed a study where ultraviolet (UV) and 3D printing were used to manufacture tablets to treat Parkinson's disease. Martin Wallace, director of GSK Technology, said that GSK is investing in 3D printing advantages to manufacture pills and tablets. Also, in 2015, Aprecia pharmaceutical company launched 'ZipDose' technology which manufactures 3D printed drugs.

The drug manufacturers must comply with the CGMP (Current Good Manufacturing Practice) regulations that come under the US Food and Drug Administration (FDA) which includes generic pharmaceuticals. The CGMP regulations require manufacturers to maintain a minimum quality standard for the methods, controls, and facilities used in manufacturing, packaging, and processing of drug product. The part- 99 of chapter 1 under title 21-Food And Drugs of CFR (Code of Federal Regulations) contains subparts from A to H. The whole part-99 describes the guidelines that need to be followed by drug manufacturers regarding the dissemination of information on human drugs, including biologics, and devices. The guidelines concern with the safety, effectiveness, or benefit of use that is not included in the approved labeling for a drug or device approved by the Food and Drug Administration for marketing. The guidelines regulate the information regarding the drugs that should be delivered to the health care practitioner, pharmacy benefit manager, health insurance issuer, group health plan, or federal or state government agency.

In March 2018, GlaxoSmithKline plc (GSK), a British multinational pharmaceutical company acquired Novartis for $13 Billion. GSK bought a 100% ownership of Novartis' consumer healthcare business. With this acquisition, GSK plans to broaden its portfolio and boost adjusted earnings and cash flows. Also, with the money received from this acquisition, Novartis plans to have new technologies and product to fit into their core therapeutic area. Novartis is a pharmaceutical company that has a diverse portfolio of innovative and cost-saving generic medicines.

Major players in the market are Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.) and Sun Pharmaceutical.

    1. Executive Summary

    2. Generic Pharmaceuticals Market Characteristics

    3. Generic Pharmaceuticals Market Size And Growth

    3.1. Global Generic Pharmaceuticals Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Generic Pharmaceuticals Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Generic Pharmaceuticals Market Segmentation

    4.1. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    CNS

    Cardiovascular

    Dermatology

    Genitourinary/Harmonal

    Respiratory

    Rheumatology

    Diabetes

    Oncology

    4.2. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    4.3. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Biosimilar

    Simple Generic

    Super Generic

    4.4. Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Oral

    Inectables

    Dermal/Topical

    Inhaler

    5. Generic Pharmaceuticals Market Regional And Country Analysis

    5.1. Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Generic Pharmaceuticals Market  

    6.1. Asia-Pacific Generic Pharmaceuticals Market Overview  

    6.2. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Generic Pharmaceuticals Market  

    7.1. China Generic Pharmaceuticals Market Overview  

    7.2. China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Generic Pharmaceuticals Market  

    8.1. India Generic Pharmaceuticals Market Overview  

    8.2. India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Generic Pharmaceuticals Market  

    9.1. Japan Generic Pharmaceuticals Market Overview  

    9.2. Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Generic Pharmaceuticals Market  

    10.1. Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Generic Pharmaceuticals Market  

    11.1. Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Generic Pharmaceuticals Market  

    12.1. South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Generic Pharmaceuticals Market  

    13.1. Western Europe Generic Pharmaceuticals Market Overview

    13.2. Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Generic Pharmaceuticals Market  

    14.1. UK Generic Pharmaceuticals Market Overview

    14.2. UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Generic Pharmaceuticals Market  

    15.1. Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Generic Pharmaceuticals Market  

    16.4. France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.5. France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Generic Pharmaceuticals Market  

    17.1. Eastern Europe Generic Pharmaceuticals Market Overview

    17.2. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Generic Pharmaceuticals Market  

    18.1. Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Generic Pharmaceuticals Market  

    19.1. North America Generic Pharmaceuticals Market Overview

    19.2. North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Generic Pharmaceuticals Market  

    20.1. USA Generic Pharmaceuticals Market Overview

    20.2. USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Generic Pharmaceuticals Market  

    21.1. South America Generic Pharmaceuticals Market Overview

    21.2. South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Generic Pharmaceuticals Market  

    22.1. Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Generic Pharmaceuticals Market  

    23.1. Middle East Generic Pharmaceuticals Market Overview

    23.2. Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Generic Pharmaceuticals Market  

    24.1. Africa Generic Pharmaceuticals Market Overview

    24.2. Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Generic Pharmaceuticals Market Competitive Landscape And Company Profiles

    25.1. Generic Pharmaceuticals Market Competitive Landscape

    25.2. Generic Pharmaceuticals Market Company Profiles

    25.2.1. Teva Pharmaceuticals

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Mylan NV

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Sandoz International GmbH

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Hospira (Pfizer Inc.)

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Sun Pharmaceutical

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market

    27. Generic Pharmaceuticals Market Trends And Strategies

    28. Generic Pharmaceuticals Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: China, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: China, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: India, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: India, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: Japan, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: Japan, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Australia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Australia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Indonesia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: Indonesia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: South Korea, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: South Korea, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Western Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: Western Europe, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: UK, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: UK, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: Germany, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: Germany, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: France, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: France, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: Russia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: Russia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: North America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: North America, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: USA, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: USA, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: South America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: South America, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: Brazil, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Brazil, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Middle East, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Middle East, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Africa, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Africa, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 47: Teva Pharmaceuticals Financial Performance
  • Table 48: Mylan NV Financial Performance
  • Table 49: Sandoz International GmbH Financial Performance
  • Table 50: Hospira (Pfizer Inc.) Financial Performance
  • Table 51: Sun Pharmaceutical Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: China, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: China, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: India, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: India, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: Japan, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: Japan, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Australia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Australia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: Indonesia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: South Korea, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: South Korea, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: Western Europe, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: UK, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: UK, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: Germany, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: Germany, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: France, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: France, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: Russia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: Russia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: North America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: North America, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: USA, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: USA, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: South America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: South America, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: Brazil, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Brazil, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Middle East, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Middle East, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Africa, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Africa, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 47: Teva Pharmaceuticals Financial Performance
  • Figure 48: Mylan NV Financial Performance
  • Figure 49: Sandoz International GmbH Financial Performance
  • Figure 50: Hospira (Pfizer Inc.) Financial Performance
  • Figure 51: Sun Pharmaceutical Financial Performance
Innovations In The Diabetes Therapies Market
Read More
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Read More
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
Read More
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Read More
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Read More
Developments in Drug Discovery Procedures Will Aid Market Growth For Diabetes Therapies
Read More
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Read More
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Read More
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2021
View Report
Cardiovascular Drugs Global Market Report 2020
View Report
Dermatology Drugs Global Market Report 2020
View Report
Gastrointestinal Drugs Global Market Report 2020
View Report
Hematology Drugs Global Market Report 2020
View Report
Metabolic Disorders Drugs Global Market Report 2020
View Report
Musculoskeletal Disorders Drugs Global Market Report 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)